Search
Inogen Inc
INGNAdd to Watchlist
6.600USD
-0.050-0.75%
Close 07/02, 13:00（ET）Quotes delayed by 15 min
179.73MMarket Cap
LossP/E TTM
View Detailed Chart
TradingKey 图表Intraday
1m
30m
1h
D
W
M
D
Today
-0.75%
5 Days
-4.90%
1 Month
+4.60%
6 Months
-0.45%
Year to Date
-1.79%
1 Year
-11.88%
Key Figures
6.630Open
6.800High
217.41KVolume
LossP/E TTM
LossP/E Dynamic
--Dividend TTM
0.80%Turnover Ratio
6.650Prev. Close
6.425Low
1.06MTurnover
LossP/E Static
0.93P/B
0.00%Div Yield TTM
-8.38%ROA
9.13052wk High
1.17Volume Ratio
-35.89MNet Profit
27.23MShares
-0.9144EPS TTM
1.61Beta
-13.07%ROE
5.34052wk Low
5.64%Amplitude
44.49%Gross Margin
179.73MMarket Cap
1.92Reward/Risk
2.81%Risk Rate
TradingKey Stock Score of Inogen Inc
Currency: USD Updated: 2026-07-02Key Insights
Inogen Inc's fundamentals are relatively very healthy, and its growth potential is high.Its valuation is considered fairly valued, ranking 66 out of 204 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 12.00.In the medium term, the stock price is expected to remain stable.Despite an average stock market performance over the past month, the company shows strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Inogen Inc's Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Media Coverage
Last 24 hours
Coverage Level
Very Low
Very High
Negative
Inogen Inc Highlights
StrengthsRisks
Inogen, Inc. is a medical technology company offering respiratory products for use in the homecare setting. It supports patient respiratory care by developing, manufacturing, and marketing portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. Its Inogen One and Inogen Rove systems concentrate the air around the patient to offer a source of supplemental oxygen with a battery and can be plugged into an outlet when at home, in a car, or in a public place with outlets available. Its Inogen One and Inogen Rove systems reduce the patient’s reliance on stationary concentrators and scheduled deliveries of tanks with a finite supply of oxygen. Inogen Connect is a wireless connectivity platform for the Inogen One G4, Inogen One G5, Inogen Rove 4, and Inogen Rove 6, consisting of a front-end mobile application for use by long-term oxygen therapy users. It offers Simeox, which is an airway clearance device.
Undervalued
The company’s latest PE is -7.22, at a low 3-year percentile range.
Institutional Selling
The latest institutional holdings are 20.74M shares, decreasing 13.68% quarter-over-quarter.
Held by Bill Nygren | OAKMX
Star Investor Bill Nygren | OAKMX holds 262.92K shares of this stock.
Analyst Rating
Based on
3
analysts
Buy
Current Rating
12.000
Target Price
+80.45%
Upside Space
Inogen Inc News
More news coming soon, stay tuned...
Financial Indicators
EPS
Relevant data have not been disclosed by the company yet.
Total revenue
Relevant data have not been disclosed by the company yet.
Inogen Inc Info
Inogen, Inc. is a medical technology company offering respiratory products for use in the homecare setting. It supports patient respiratory care by developing, manufacturing, and marketing portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. Its Inogen One and Inogen Rove systems concentrate the air around the patient to offer a source of supplemental oxygen with a battery and can be plugged into an outlet when at home, in a car, or in a public place with outlets available. Its Inogen One and Inogen Rove systems reduce the patient’s reliance on stationary concentrators and scheduled deliveries of tanks with a finite supply of oxygen. Inogen Connect is a wireless connectivity platform for the Inogen One G4, Inogen One G5, Inogen Rove 4, and Inogen Rove 6, consisting of a front-end mobile application for use by long-term oxygen therapy users. It offers Simeox, which is an airway clearance device.
Ticker SymbolINGN
CompanyInogen Inc
CEOSmith (Kevin R. M)
Websitehttps://www.inogen.com/
Related Instruments
-0.37%
+1.91%
+3.48%
+5.87%
+2.10%
-0.10%
+4.19%
+5.03%
+4.30%
+0.25%
+3.65%
+4.74%
+2.79%
+2.59%
-3.06%
+3.40%
+3.76%
+1.10%
+0.28%
-2.09%Popular Instruments
52852.900
+10.400 (+0.02%)
29669.900
+358.500 (+1.22%)
7507.800
+36.300 (+0.49%)
14963.000
+160.000 (+1.08%)
69676.000
+1528.000 (+2.24%)
6412.400
+59.600 (+0.94%)
68.683
+0.339 (+0.50%)
308.630
+14.250 (+4.84%)
194.830
-2.750 (-1.39%)
4174.610
+52.700 (+1.28%)
FAQs
What is the current price of Inogen Inc (INGN)?
The current price of Inogen Inc (INGN) is 6.60.
What is the symbol of Inogen Inc?
The ticker symbol of Inogen Inc is INGN.
What is the 52-week high of Inogen Inc?
The 52-week high of Inogen Inc is 9.13.
What is the 52-week low of Inogen Inc?
The 52-week low of Inogen Inc is 5.34.
What is the market capitalization of Inogen Inc?
The market capitalization of Inogen Inc is 179.73M.
Is Inogen Inc (INGN) currently rated as Buy, Hold, or Sell?
According to analysts, Inogen Inc (INGN) has an overall rating of Buy, with a price target of 12.00.
What is the Earnings Per Share (EPS TTM) of Inogen Inc (INGN)?
The Earnings Per Share (EPS TTM) of Inogen Inc (INGN) is -0.86.